Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers January 20, 2019
Pharmacy Choice - News - Over-the-Counter Drugs - January 20, 2019

Pharmacy News

 Over-the-Counter Drugs
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 24 of 24     Go To Page:

1/19/19 - Jon Lender: Doctor pleads guilty in compound medicine case that defrauded Connecticut taxpayers [The Hartford Courant]
Jan. 19 A physician pleaded guilty Friday in U.S. District Court in New Haven to a count of conspiracy to commit health care fraud in an alleged scheme with her husband to defraud Connecticut's state-employee prescription benefit plan, as well as other government health programs, by submitting prescriptions for very expensive "compound medicati
1/18/19 - Statement from FDA Commissioner Scott Gottlieb, M.D., on unprecedented new efforts to support development of over-the-counter naloxone to help reduce opioid overdose deaths
With the number of overdose deaths involving prescription and illicit opioids more than doubling over the last seven years to nearly 48,000 in 2017, it's critical that we continue to address this tragedy from all fronts. This includes new ways to increase availability of naloxone, a drug used to treat opioid overdose. When someone overdoses on an o
1/18/19 - The FDA Bends Over Backwards To Get Drug Makers To Ask Them To Make Naloxone OTC
Press reports have created the impression that the opioid overdose antidote naloxone is now available over the counter. To get around such obstacles, Australia and Italy have designated naloxone as a truly over-the-counter drug. The Food and Drug Administration is on record since at least 2016 as believing that it is probably appropriate for naloxo
1/17/19 - Drug-Loaded Oral Thin Films Market Foraying Into Emerging Economies 2018 to 2026
Rockville, MD 01/16/2019 The oral route for drug administration takes up more than 50% of the available drug in the market. Drug-loaded oral thin films have composed drug quantity that is administered via mouth. The composition of drug-loaded oral thin films not only require API but need supporting biocompatible ingredients such as strip form
1/17/19 - FDA Accepts Genentech's Supplemental Biologics License Application for Tecentriq Plus Chemotherapy (Abraxane and Carboplatin) for the Initial Treatment of Metastatic Non-Squamous Non-Small Cell Lung Cancer
Genentech, a member of the Roche Group, today announced that the U.S. Food and Drug Administration has accepted the company s supplemental Biologics License Application for Tecentriq in combination with Abraxane and carboplatin for the initial treatment of people with metastatic non-squamous non-small cell lung cancer who do not have EGFR
1/17/19 - Global Intranasal Drug Delivery Industry
Company profiles are primarily based on public domain information including company URLs. The report profiles 64 companies including many key and niche players such as:- Aegis Therapeutics LLC- AptarGroup, Inc.- AstraZeneca Plc- Becton Dickinson and Company- GlaxoSmithKline Plc- Johnson& Johnson Inc. Read the full report:...
1/17/19 - House Energy & Commerce Committee Issues Report on Activity for 115th Congress (Part 11 of 13)
To amend the Public Health Service Act to authorize the Director of the Centers for Disease Control and Prevention to carry out certain activities to prevent controlled substances overdoses, and for other purposes. H.R. 5812 was introduced by Representative H. Morgan Griffith on May 15, 2018, and referred to the Committee on Energy and Commerce.
1/17/19 - House Energy & Commerce Committee Issues Report on Activity for 115th Congress (Part 8 of 13)
The House Energy and Commerce Committee issued a report on activity for the 115th Congress. H.R. 7 was introduced by Representative Christopher H. Smith on January 13, 2017, and referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means and Committee on the Judiciary. On January 13, 2017, H.R. 7 was conside
1/17/19 - Hunt Valley contract drug manufacturer appoints new CEO [News Central Asia]
Pharmaceutics International Inc., a contract drug development and manufacturing firm in Hunt Valley, announced Tuesday that it has appointed Kurt R. Neilsen as its new president and CEO. Neilsen most recently was president of Lupin Somerset, a New Jersey manufacturing plant for Lupin Ltd., the Mumbai, India- based drug maker whose U.S. headquarters
1/17/19 - NetworkNewsBreaks The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTC: TGODF) Names Chief Science Officer
The Green Organic Dutchman Holdings (TSX: TGOD) (OTCQX: TGODF), a cannabis-focused research and development company, today announced the appointment of Dr. Rav Kumar, PhD as Chief Science Officer. Dr. Kumar will utilize his more than 25 years of experience in the pharmaceutical industry to lead TGOD's Science & Innovation Division. He will also o
1/17/19 - Older people who use hearing aids still report hearing challenges
By a News Reporter-Staff News Editor at Managed Care Weekly Digest A high proportion of older people with hearing aids, especially those with lower incomes, report having trouble hearing and difficulty accessing hearing care services, according to a study from researchers at Johns Hopkins Bloomberg School of Public Health. "This study highlights
1/17/19 - OURS: Allow access to CBD oils
Senate Bill 22 is one of those pieces of legislation that does more than it says as members of the Senate's Health and Human Services Committee learned Tuesday. The Department of Health submitted the bill, which its attorney testified merely allows South Dakotans to purchase Epidiolex, a marijuana-derived cannabidiol, or CBD, oil approved in 2018 b
1/17/19 - Pfizer partners with Medochemie to make drugs in Vietnam [Sport360]
Pfizer will transfer technology that will permit Medochemie to manufacture 11 of Pfizers products, including four sterile injectables and seven tablets. The partnership is aligned with the Vietnam governments vision to boost and promote the development of the local pharmaceutical industry, Pfizer spokesperson Roma Nair said in an email.
1/17/19 - Statement From FDA Commissioner Scott Gottlieb, M.D., on Unprecedented New Efforts to Support Development of Over-the-counter Naloxone to Help Reduce Opioid Overdose Deaths
The U.S. Department of Health and Human Services' Food and Drug Administration issued the following statement by Commissioner Scott Gottlieb on the unprecedented efforts to support development of over-the-counter naloxone to help reduce opioid overdose deaths:. "With the number of overdose deaths involving prescription and illicit opioids more tha
1/16/19 - Hunt Valley contract drug manufacturer appoints new CEO [The Baltimore Sun]
Jan. 16 Pharmaceutics International Inc., a contract drug development and manufacturing firm in Hunt Valley, announced Tuesday that it has appointed Kurt R. Neilsen as its new president and CEO. Neilsen most recently was president of Lupin Somerset, a New Jersey manufacturing plant for Lupin Ltd., the Mumbai, India- based drug maker whose U.S. he
1/16/19 - NetworkNewsBreaks BriaCell Therapeutics Corp (OTC: BCTXF) (TSX.V: BCT) Advancing Development of Bria-IMT? as Immunotherapy Solution for Advanced Breast Cancer Patients
BriaCell Therapeutics (OTC: BCTXF) (TSX.V: BCT), a biotechnology company developing targeted, safe treatments for cancer, is advancing the development of its lead product candidate Bria-IMT?, which has demonstrated positive results in three clinical studies to date. An article discussing the company reads, Bria-IMT? works by providing breast
1/15/19 - Active Pharmaceutical Ingredient (API) Market, 2024 by Type (Innovative, Generic), Manufacturer (Captive, Merchant), Synthesis (Synthetic, Biotech), Product (mAb, Hormone, Biosimilar) Drug (OTC, Rx)
The global APIs market is projected to reach USD 245.2 billion by 2024 from USD 182.2 billion in 2019, at a CAGR of 6.1% during the forecast period. Geographically, the active pharmaceutical ingredients market is segmented into North America, Europe, Asia, and the Rest of the World. In 2019, North America is expected to dominate the market, followe
1/15/19 - Active Pharmaceutical Ingredient (API) Market, 2024 by Type (Innovative, Generic), Manufacturer (Captive, Merchant), Synthesis (Synthetic, Biotech), Product (mAb, Hormone, Biosimilar) Drug (OTC, Rx) - ResearchAndMarkets.com
The global APIs market is projected to reach USD 245.2 billion by 2024 from USD 182.2 billion in 2019, at a CAGR of 6.1% during the forecast period. Geographically, the active pharmaceutical ingredients market is segmented into North America, Europe, Asia, and the Rest of the World. In 2019, North America is expected to dominate the market, followe
1/15/19 - Global Active Pharmaceutical Ingredient Market Research Report 2019-2024: Growing Adoption of Artificial Intelligence-Based Tools for Drug Discovery
The "Active Pharmaceutical Ingredient/ API Market by Type, Manufacturer, Synthesis, Product Drug, Therapy, and Region- Global Forecast to 2024" report has been added to ResearchAndMarkets.com' s offering. The global APIs market is estimated to reach USD 245.2 billion by 2024 from USD 182.2 billion in 2019, at a CAGR of 6.1% during the forecast peri
1/15/19 - Restoring Custodian Of Drugs To Pharmacists [Daily Independent (Nigeria)]
LAGOS- It is no secret that Nigerian youths are increasingly turning from street drugs to prescription drugs for recreation or to enhance academic performance. To curb the ugly trend, experts and stakeholders, especially the pharmaceutical Society of Nigeria have advocated for pharmacists to be given full control of drug distribution and use in the
1/15/19 - Takeda rings NYSE opening bell after listing
The listing came as Takeda aims to increase sales in medicines for rare diseases such as hemophilia and expand its business in the key U.S. market through the deal. The Tokyo- based Takeda is also listed on the Tokyo Stock Exchange. After acquiring Shire, Takeda plans to expand research and development spending to more than 400 billion yen annually
1/15/19 - Tetra Natural Health Adds New Leaders to its Commercial Operations [T-break Tech (Middle East)]
-Tetra Natural Health, a subsidiary of Tetra Bio-Pharma Inc., a leader in cannabinoid-based drug discovery and development, is pleased to announce that Mr. Derek Theriault has been hired as National Sales Director and Michael Olders has been hired as Director Operations and Logistics. Derek Theriault, National Sales Director has 20 years experience
1/14/19 - Tetra Natural Health Adds New Leaders to its Commercial Operations
Tetra Natural Health, a subsidiary of Tetra Bio-Pharma Inc., a leader in cannabinoid-based drug discovery and development, is pleased to announce that Mr. Derek Theriault has been hired as National Sales Director and Michael Olders has been hired as Director Operations and Logistics. Michael Olders, Director Operations and Logistics With more
1/13/19 - The pros and cons of mail-order pharmacies
Plus, it's easy to get all your medication refilled and shipped at one time and is usually more affordable, "says Mohamed Jalloh, a pharmacist and the official spokesman for the American Pharmacists Association. As early as the mid-1970s, VA, formerly known as the Veterans Administration, operated regional pharmacies where prescriptions were filled
Articles(s): 1 - 24 of 24     Go To Page:


© 2019 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Legal & Practical Issues in Compounding Pharmacy
This lesson is supported by:
RxSchool
Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
RxSchool
Pharmacy Spanish
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2019 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415